Biologics Outsourcing Market

The "Global Biologics Outsourcing Market" size was valued at US$ 14.56 billion in 2024 and is projected to reach US$ 28.92 billion by 2030, at a CAGR of 12.1% during the forecast period 2024-2030.

The "United States Biologics Outsourcing Market" size was valued at US$ 3.82 billion in 2024 and is projected to reach US$ 7.38 billion by 2030, at a CAGR of 11.6% during the forecast period 2024-2030.

Biologics outsourcing refers to the practice of pharmaceutical and biotechnology companies contracting third-party service providers for the production, research, and development of biologic products. Biologics are complex drugs made from living organisms, and outsourcing can cover a range of services, including drug development, manufacturing, clinical trials, and distribution. Companies typically turn to contract manufacturing organizations (CMOs), contract research organizations (CROs), or other specialized service providers to leverage their expertise, infrastructure, and cost-effective solutions. Outsourcing biologics helps companies accelerate time-to-market, reduce costs, and focus on core competencies while ensuring high-quality production that meets regulatory standards.

Contract development and manufacturing services for biological pharmaceuticals, including protein production, cell line development, and process optimization capabilities.

Report Overview

Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.

Biologics Outsourcing Market provides a deep insight into the global Biologics Outsourcing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Outsourcing Market, Biologics Outsourcing Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, Biologics Outsourcing Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics Outsourcing market in any manner.

Global Biologics Outsourcing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Boehringer Ingelheim
• Catalent
• GenScript
• Innovent Biologics
• Syngene
• Shanghai Medicilon
• GL Biochem Corporation
• GVK Biosciences Private
• Horizon Discovery Group
• Selexis
• Lonza
• Abzena
• Adimab

By Type

• Antibody
• Recombinant
• Protein
• Vaccines
• Others

By Application

• Vaccine & Therapeutics Development
• Blood & Blood Related Products Testing
• Cellular and Gene Therapy
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Biologics Outsourcing Market
• Overview of the regional outlook of the Biologics Outsourcing Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter